AMYLEX Trademark
Trademark Overview
On Wednesday, March 25, 1981, a trademark application was filed for AMYLEX with the United States Patent and Trademark Office. The USPTO has given the AMYLEX trademark a serial number of 73302731. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, September 16, 1983. This trademark is owned by R-KANE PRODUCTS, INC.. The AMYLEX trademark is filed in the Pharmaceutical Products category with the following description:
WEIGHT REDUCING AGENT
General Information
| Serial Number | 73302731 |
| Word Mark | AMYLEX |
| Filing Date | Wednesday, March 25, 1981 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Friday, September 16, 1983 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | WEIGHT REDUCING AGENT |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 018 |
| Class Status Code | 8 - Abandoned |
| Class Status Date | Wednesday, August 4, 1999 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, March 19, 1981 |
| First Use In Commerce Date | Thursday, March 19, 1981 |
Trademark Owner History
| Party Name | R-KANE PRODUCTS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | PENNSAUKEN, NJ 08110 |
Trademark Events
| Event Date | Event Description |
| Friday, September 16, 1983 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, March 15, 1982 | NON-FINAL ACTION MAILED |
| Thursday, February 18, 1982 | ASSIGNED TO EXAMINER |
